Original research Bifidobacterium breve LE4 Reduces Alzheimer's Disease Pathology and Confers Neuroprotection by Attenuating Neuroinflammation, Restoring Metabolism, and Preserving Gut Barrier
Emerging evidence implicates gut microbiota dysbiosis in Alzheimer's disease (AD) pathogenesis, suggesting probiotic interventions as a viable therapeutic strategy. This study systematically screened 18 Bifidobacterium strains, among which Bifidobacterium breve LE4 exhibited both potent antioxidant activity and lip...